View of Pharmacoeconomic analysis of the genomic test Mammaprint® use for breast cancer patients treated at a private health institution in Brazil

Return to Article Details Pharmacoeconomic analysis of the genomic test Mammaprint® use for breast cancer patients treated at a private health institution in Brazil Download Download PDF